Treatment of intractable depression.
D000547:Amantadine / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D003863:Depression / Q000188:drug therapy / Q000628:therapy*; D003913:Dextroamphetamine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D008774:Methylphenidate / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D012110:Reserpine / Q000627:therapeutic use; D012892:Sleep Deprivation; D014364:Tryptophan / Q000627:therapeutic use; D014815:Vitamins / Q000627:therapeutic use
D000928:Antidepressive Agents; D006728:Hormones; D008996:Monoamine Oxidase Inhibitors; D014815:Vitamins; D008774:Methylphenidate; D012110:Reserpine; D014364:Tryptophan; D008094:Lithium; D000547:Amantadine; D003913:Dextroamphetamine